id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1146319,df45bb38-c683-42c7-acea-e5c0bcbd514e,Q3,HOLLAND & KNIGHT LLP,18466,ALLIANCE FOR REGENERATIVE MEDICINE,2011,third_quarter,HCR,"Advocate for funding for regenerative medicine companies;  NIH funding for regenerative medicine research; funding for FDA to perform regulatory research and creation of federal coordinating entity for regenerative medicine.  Advocate for new/modified regulations re:  FDA aprroval of regenerative medicine products.  Work with NIST to explore collaborations re: manfacturing standards; Lobbied in support of HR 1862, The Regenerative Medicine Promotion Act of 2011.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),SENATE",80000,,0,0,2011-10-11T11:32:10.710000-04:00